References

References citing our products:

Product Line Allele & cat# Journal Year Title Authors DOI PMID
Empty Loadable HLA-A*02:01 (cat. #HA02-070), HLA-A*24:02 (cat. #HA24-025),  H-2Kb (cat. #MKb-016) Science Immunology 2019 Empty peptide-receptive MHC class I molecules for efficient detection of antigen-specific T cells Saini SK, Tamhane T, Anjanappa R, et al. https://doi.org/10.1126/sciimmunol.aau9039 31324690
Empty Loadable HLA-A*02:01 (cat. #HA02-070) Cell Press Immunity 2020 Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein Ferretti AP, Kula T, Wang Y, et al. https://doi.org/10.1016/j.immuni.2020.10.006 33128877
pMHC H-2Kb/SIINFEKL (cat. #MKb-001) Nature Scientific Reports 2021 Site-specific antigen-adjuvant conjugation using cell-free protein synthesis enhances antigen presentation and CD8+ T-cell response Weiss AM, Ajit J, Albin TJ, et al. https://doi.org/10.1038/s41598-021-85709-1 33737644
Empty Loadable HLA-A*02:01 (cat. #HA02-070) Viruses 2021 Lipofection with Synthetic mRNA as a Simple Method for T-Cell Activation/Assay Jarzebska NT, Frei J, Lauchli S, et al. https://doi.org/10.3390/v13071232 34202260
Empty Loadable H-2Kb (cat. #MKb-016) Frontiers Immunology 2021 Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents Bošnjak B, Odak I, Barros-Martins J, et al. https://doi.org/10.3389/fimmu.2021.772240 34858430
pMHC Oxford Academic PEDS 2022 Immortalization and functional screening of natively paired human T cell receptor repertoires Fahad AS, Chung CY, Lopez Acevedo SN, et al. https://doi.org/10.1093/protein/gzab034 35174859
Empty Loadable HLA-A*02:01 (cat. #HA02-070) Frontiers Immunology 2022 Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression Carnaz Simões AM, Holmström MO, Aehnlich P, et al. https://doi.org/10.3389/fimmu.2022.866610 35603202
Journal for ImmunoTherapy of Cancer 2022 P09.23 Immune cell infiltration as a novel marker for predicting patient outcome in nephroblastoma Watzke L, Sorger H, Palmisani F, Metzelder M, Amann G, Bergmann M. https://doi.org/10.1136/jitc-2022-ITOC9.79
pMHC H-2Kb/SIINFEKL (cat. #MKb-001) Journal for ImmunoTherapy of Cancer 2022 Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies Hägerbrand K, Varas L, Deronic A, et al. https://doi.org/10.1136/jitc-2022-005018 36323431
Empty Loadable H-2Kb (cat. #MKb-016) Nature 2022 T cells specific for α-myosin drive immunotherapy-related myocarditis Axelrod ML, Meijers WC, Screever EM, et al. https://doi.org/10.1038/s41586-022-05432-3  36385524
pMHC H-2Kb/SIINFEKL (cat. #MKb-001) Taylor & Francis OncoImmunology 2022 RNA with chemotherapeutic base analogues as a dual-functional anti-cancer drug Jarzebska NT, Tusup M, Frei J, et al. https://doi.org/10.1080/2162402X.2022.2147665  36419823
pMHC HLA-A*02:01/GLATEKSRW (cat. #HA02-164), HLA-A*02:01/GLATEKSRWS (cat. #HA02-165), HLA-A*02:01/GLATVKSRW (cat. #HA02-166), HLA-A*02:01/GLATVKSRWS (cat. #HA02-167) Thieme Hormone and Metabolic Research 2022 BRAFV600E and BRAF-WT Specific Antitumor Immunity in Papillary Thyroid Cancer Tian XM, Xiang B, Jin LM, et al. https://doi.org/10.1055/a-1971-7019  36427494
Empty Loadable H-2Kb (cat. #MKb-016) Cell Press STAR Protocols 2023 Screening self-peptides for recognition by mouse alloreactive CD8+ T cells using direct ex vivo multimer staining Son ET, Paul-Heng M, Leong M, et al. https://doi.org/10.1016/j.xpro.2022.101943  36525346
pMHC HLA-A*02:01/YLQPRTFLL (cat. #HA02-169), HLA-A*02:01/GILGFVFTL (cat. #HA02-012) Cell Press Reports 2023 Vaccination provides superior in vivo recall capacity of SARS-CoV-2-specific memory CD8 T cells Kavazović I, Dimitropoulos C, Gašparini D, et al. https://doi.org/10.1016/j.celrep.2023.112395  37099427
pMHC H-2Kb/SIINFEKL (cat. #MKb-001) ScienceDirect Biomaterials 2023 Robust tolerogenic dendritic cells via push/pull pairing of toll-like-receptor agonists and immunomodulators reduces EAE Deak P, Knight HR, Esser-Kahn A. https://doi.org/10.1016/j.biomaterials.2022.121571  35597168
pMHC H-2Kb/SIINFEKL (cat. #MKb-001) npj Vaccines 2023 DNA based neoepitope vaccination induces tumor control in syngeneic mouse models Viborg N, Pavlidis MA, Barrio-Calvo M, et al. https://doi.org/10.1038/s41541-023-00671-5  37244905
Empty Loadable HLA-A*02:01 (cat. #HA02-070) Nature Communications 2023 A T-cell antigen atlas for meningioma: novel options for immunotherapy Medici G, Freudenmann LK, Velz J, et al. https://doi.org/10.1007/s00401-023-02605-w  37368072
pMHC H-2Kb/VNFNFNGL (cat. #MKb-023) , H-2Kb/LALLLLDRL (cat. #MKb-024), H-2Kb/TSYKFESV (cat. #MKb-002) Pharmaceutics 2023 What We Learned about the Feasibility of Gene Electrotransfer for Vaccination on a Model of COVID-19 Vaccine Kamensek U, Cemazar M, Kranjc Brezar S, et al. https://doi.org/10.3390/pharmaceutics15071981  37514166
pMHC H-2Kb/KMYQYARL Taylor & Francis OncoImmunology 2023 Effective intravenous delivery of adenovirus armed with TNFα and IL-2 improves anti-PD-1 checkpoint blockade in non-small cell lung cancer Kudling TV, Clubb JHA, Pakola S, et al. https://doi.org/10.1080/2162402X.2023.2241710  37546696
pMHC H-2Kd/KFKASRASI (cat. #MKd-008) Frontiers Immunology 2023 Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine Barrio-Calvo M, Kofoed SV, Holste SC, et al. https://doi.org/10.3389/fimmu.2023.1234912  37720215
Empty Loadable HLA-A*24:02 (cat. #HA24-025) Nature 2023 Targeting of intracellular oncoproteins with peptide-centric CARs Yarmarkovich M, Marshall QF, Warrington JM, et al. https://doi.org/10.1038/s41586-023-06706-0   37938771
pMHC H-2Kb/SIINFEKL (cat. #MKb-001) Nature 2024 Hepatocytes coordinate immune evasion in cancer via release of serum amyloid A proteins Stone ML, Lee J, Lee JW, et al. https://doi.org/10.1038/s41590-024-01820-1  38641718
pMHC HLA-A∗02:01/NLVPMVATC (Cat. # HLA02-010) Cell Press Reports 2024 NKp44/HLA-DP-dependent regulation of CD8 effector T cells by NK cells Padoan B, Casar C, Krause J, et al. https://doi.org/10.1016/j.celrep.2024.114089  38615318
Empty Loadable HLA-A02:01(cat. #HA02-070), HLA-A11:01 (Cat. # HA11-006) Frontiers Immunology 2024 Refined analytical pipeline for the pharmacodynamic assessment of T-cell responses to vaccine antigens Pavlidis MA, Viborg N, Lausen M, Rønø B, Kleine-Kohlbrecher D. https://doi.org/10.3389/fimmu.2024.1404121   38720900
Empty Loadable HLA-A*02:01 (cat. #HA02-070), HLA-A*03:01 (cat. #HA03-001) , HLA-A*11:01 (cat. #HA11-006), HLA-A*24:02 (cat. #HA24-025) Frontiers Immunology 2024 Torque teno viruses exhaust and imprint the human immune system via the HLA-E/NKG2A axis Vietzen H, Simonitsch C, Friedel B, et al. https://doi.org/10.3389/fimmu.2024.1447980  39295866
pMHC mCD1d/αGC (Cat. #MCD1d-001) Nature Communications Biology 2024 An intranasal cationic liposomal polysaccharide vaccine elicits humoral immune responses against Streptococcus pneumoniae Wei P, Romanò C, Li C, et al. https://doi.org/10.1038/s42003-024-06806-1  39284859
pMHC AACR Journals Cancer Discovery 2024 TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer Kortleve D, Hammerl D, van Brakel M, et al. https://doi.org/10.1158/2159-8290.CD-24-0168  39172012
pMHC Nature Communications 2025 Mapping naturally presented T cell antigens in medulloblastoma based on integrative multi-omics Velz J, Freudenmann LK, Medici G, et al. https://doi.org/10.1038/s41467-025-56268-0   39904979
pMHC H-2Kb/SIINFEKL (cat. #MKb-001) Cell Press Immunity 2025 Metallophilic marginal zone macrophages cross-prime CD8+ T cell-mediated protective immunity against blood-borne tumors Mauvais FX, Hamel Y, Silvin A, et al. https://doi.org/10.1016/j.immuni.2025.02.027   40139188
pMHC, Empty Loadable HLA-A*24:02 (cat. #HA24-025) Frontiers Immunology 2025 Bispecific antibody targeting shared indel-derived neoantigen of APC Effenberger C, Wu X, Zhao P, Matsumoto S, Nakamura Y, Kiyotani K. https://doi.org/10.3389/fimmu.2025.1574958  40443649
pMHC HLA-A*24:02 Frontiers Immunology 2025 Identification of shared neoantigens derived from frameshift mutations in the APC gene Zhao P, Effenberger C, Matsumoto S, Tanaka T, Nakamura Y, Kiyotani K. https://doi.org/10.3389/fimmu.2025.1574955  40443655
pMHC H-2Kb/SIINFEKL (cat. #MKb-001) Taylor & Francis Drug Delivery 2025 Antigenic peptide delivery to antigen-presenting cells using a CD40-coiled coil affinity-based platform Nyesiga B, Hägerbrand K, Varas L, et al. https://doi.org/10.1080/10717544.2025.2486340  40417977
pMHC H-2Kd/KFKASRASI Nature Immunotherapy 2025 Preclinical evaluation of a CCL19 immune-potentiated DNA cancer vaccine Kofoed SV, Barrio-Calvo M, Pavlidis MA, et al. https://doi.org/10.1007/s00262-025-04120-1   40705109
Empty Loadable HLA-A*02:01 (cat. # HA02-070) Nature Molecular Medicine 2025 Targeting mutated KRAS by HLA-A*02:01 restricted anti-KRAS TCR-mimic CAR and bispecific T cell engager Ebrahimi S, Lohnes BJ, Khan SA, et al. https://doi.org/10.1007/s00109-025-02585-2   40794198
Empty Loadable H-2Kb (cat. #MKb-016) Front. Cell. Infect. Microbiol. 2023 The effect of Toll-like receptor agonists on the immunogenicity of MVA-SARS-2-S vaccine after intranasal administration in mice Do KTH, Willenzon S, Ristenpart J, et al. https://doi.org/10.3389/fcimb.2023.1259822   37854858
pMHC HLA-A*02:01/NLVPMVATV (cat. #HA02-010), HLA-A*02:01/VLEETSVML (cat. #HA02-028 ) Frontiers Immunology 2024 Frequencies of activated T cell populations increase in breast milk of HCMV-seropositive mothers during local HCMV reactivation Lazar K, Pawelec G, Goelz R, Hamprecht K, Wistuba-Hamprecht K. https://doi.org/10.3389/fimmu.2023.1258844  38235135
pMHC H-2Kb/SIINFEKL (cat. #MKb-001) Cell Press Reports 2022 Isolating and targeting a highly active, stochastic dendritic cell subpopulation for improved immune responses Deak P, Studnitzer B, Ung T, Steinhardt R, Swartz M, Esser-Kahn A. https://doi.org/10.1016/j.celrep.2022.111563   36323246
pMHC H-2Kb/SIINFEKL (cat. #MKb-001) Cell Press Cell 2025 Microbiota-derived inosine programs protective CD8+ T cell responses against influenza in newborns Stevens J, Culberson E, Kinder J, et al. https://doi.org/10.1016/j.cell.2025.05.013   38645130
pMHC H-2Kb/VNFNFNGL (cat. #MKb-023), H-2Kb/LALLLLDRL (cat. #MKb-024), H-2Kb/TSYKFESV (cat. #MKb-002) Viruses 2024 Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection Clever S, Limpinsel L, Meyer Zu Natrup C, et al. https://doi.org/10.3390/v16030417   38543782
pMHC H-2Kb/SIINFEKL (cat. #MKb-001) Journal of Extracellular Vesicles 2025 Direct delivery of immune modulators to tumour-infiltrating lymphocytes using engineered extracellular vesicles Lyu X, Yamano T, Nagamori K, et al. https://doi.org/10.1002/jev2.70035  40154979
pMHC H-2Kb/SIINFEKL (cat. #MKb-001) bioRvix 2019 Viable and efficient electroporation-based genetic manipulation of unstimulated human T cells Aksoy P, Arman Aksoy B,  Czech E , Hammerbacher J https://doi.org/10.1101/466243  
pMHC H-2Kb/SIINFEKL (cat. #MKb-001) bioRvix 2023 Surface-engineered extracellular vesicles to modulate antigen-specific T cell expansion for cancer immunotherapy Lyu X, Yamano T, Imai S, et al. https://doi.org/10.1101/2023.09.25.559260  
Empty Loadable HLA-A*02:01 (cat. #HA02-070) Preprints with the LANCET 2025 Differentiation-Induced Reduction in Functional Diversity Restricts the Ability of Cytomegalovirus-Specific CD8 T Cells to Eliminate Virus-Infected Cells Fritz L, Hassan A, Riemann L, et al. https://dx.doi.org/10.2139/ssrn.5337359  
pMHC H-2Kb/SIINFEKL (cat. #MKb-001) Nature Methods in Molecular Biology 2024 A Basic Method for Formulating mRNA-Lipid Nanoparticle Vaccines in the Lab Jarzebska NT, Frei J, Mellett M, Kündig TM, Pascolo S, Reichmuth AM. https://doi.org/10.1007/978-1-0716-3770-8_11   38814398
Empty Loadable HLA-A∗02:01 (cat. # HA02-070), HLA-A∗03:01 (cat. #HA03-001), HLA-A∗11:01 (cat. #HA11-006), HLA-A∗24:02 (cat. #HA24-025) Cell Press Cell 2023 Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis Vietzen H, Berger SM, Kühner LM, et al. https://doi.org/10.1016/j.cell.2023.11.015   38091993
pMHC HLA-A*02:01/NLVPMVATV (cat. #HA02-010) BMB Reports 2025 Modulating CD226 and PD-(L)1 pathways improves CMV-specific CD8+T cell responses in the absence of IL-2 Sim HI, Jo Y, Ahn H, et al. https://doi.org/10.5483/BMBRep.2025-0041   40495489